NAMS
NewAmsterdam Pharma Company N.V.
$37.25
+$1.08(+2.99%)
42
Overall
50
Value
45
Tech
31
Quality
Market Cap
$3.95B
Volume
766.26K
52W Range
$14.06 - $42.00
Target Price
$46.92
Key Metrics Overview
| Market Cap | $3.95B | P/E Ratio | N/A |
| 52W High | $42.00 | 52W Low | $14.06 |
| Div Yield | N/A | Payout Ratio | N/A |
| EPS Growth 3Y | -63.3% | 52W Position | 83.0% |
| Overall Score | 42 | Value Score | 50 |
| Quality Score | 31 | Technical Score | 45 |
Growth Analysis
| EPS Current Est | $-1.53 | EPS Next Est | $-2.01 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NAMS | $37.25 | +3.0% | 766.26K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get NewAmsterdam Pharma Company N.V. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW